Xijing, L., & Cheng, B. (2025). Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation. Bioorganic Chemistry, 167, N.PAG. https://doi.org/10.1016/j.bioorg.2025.109240
Chicago Style (17th ed.) CitationXijing, Liu, and Binbin Cheng. "Recent Advances in Radionuclide Drug Conjugates (RDCs) for Cancer Theranostics: From Targeted Design to Clinical Translation." Bioorganic Chemistry 167 (2025): N.PAG. https://doi.org/10.1016/j.bioorg.2025.109240.
MLA (9th ed.) CitationXijing, Liu, and Binbin Cheng. "Recent Advances in Radionuclide Drug Conjugates (RDCs) for Cancer Theranostics: From Targeted Design to Clinical Translation." Bioorganic Chemistry, vol. 167, 2025, p. N.PAG, https://doi.org/10.1016/j.bioorg.2025.109240.